Erratum to: A comparative study of DA-9601 and misoprostol for prevention of NSAID-associated gastroduodenal injury in patients undergoing chronic NSAID treatment

Erratum to: Arch. Pharm. Res. DOI 10.1007/s12272-014-0408-3

Unfortunately, the authors have made mistakes in the original version of the article. The errors should be corrected as below:

In Title (Author)

Line 2: Author ‘Jae-Young Jang’ should be corrected to ‘Jae Young Jang.’ The correct name of the author is shown in this erratum.

In Abstract

Lines 14–15: The sentence, ‘A total of 236 patients received DA 9601 and 242 received misoprostol,’ should be deleted.

In Keywords

Line 1: The word, ‘Stilen^®,’ should be corrected to ‘Stillen^®.’

In Table 1

The heading (score) and the contents of score such as 0, 1, 2 etc. in Table 1 should be center-aligned.

In Materials and methods section

Study design—Line 12: The number ‘100’ should be corrected to ‘200.’

Ethics statement—Line 24: The number ‘15’ should be corrected to ‘3-2012-0098.’

In Table 6

In the table, the contents of Misoprostol should be aligned with its heading. In the original version of the article, the heading of Misoprostol leans far to the left. Also, the 3rd line of the table should be all connected. ‘n, mean ± S.D., median, min, max,’ ‘DA-9601’ and ‘Misoprostol’ should be center-aligned. The correct version of Table 6 is shown below:

Table 6.

Difference of mean total scores for GI symptoms at week 0 and week 4

	DA-9601		Misoprostol		P value
	n, mean ± S.D., median, min, max
Week 0	236	1.4 ± 2.5, 0.0, 0.0, 19.0	242	1.1 ± 2.0, 0.0, 0.0, 9.0	0.1126a
Week 4	232	1.2 ± 2.2, 0.0, 0.0, 14.0	240	2.3 ± 3.3, 1.0, 0.0, 22.0
Difference between week 0 and week 4	232	−0.2 ± 2.8, 0.0, −15.0, 14.0	240	1.2 ± 3.2, 0.0, −6.0, 22.0	<0.0001a†
P value		0.1355b		<0.0001b†

^† P value < 0.05

^aWilcoxon rank-sum test

^bWilcoxon singed-rank test